John G. Harpel
- Molecular Biology top 10%
- Immunology and Allergy top 1%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Co-authors
- Daniel B. RifkinIrene NunesJohn S. MungerMayumi AbéChristine N. MetzDavid J. LoskutoffD B RifkinPierre‐Emmanuel Gleizes
- Topics
- Multiple Myeloma Research and Treatments (7 papers)TGF-β signaling in diseases (7 papers)Protease and Inhibitor Mechanisms (6 papers)
- Partner nations
- United States
In The Last Decade
John G. Harpel
21 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.2k
- Immunology and Allergy 385
- Oncology 353
- Pulmonary and Respiratory Medicine 309
- Cancer Research 271
Countries citing papers authored by John G. Harpel
This map shows the geographic impact of John G. Harpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Harpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Harpel more than expected).
Fields of papers citing papers by John G. Harpel
This network shows the impact of papers produced by John G. Harpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Harpel. The network helps show where John G. Harpel may publish in the future.
Co-authorship network of co-authors of John G. Harpel
This figure shows the co-authorship network connecting the top 25 collaborators of John G. Harpel. A scholar is included among the top collaborators of John G. Harpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Harpel. John G. Harpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 79 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 14 | |
| 6 | 2 | |
| 7 | 9 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 24 | |
| 13 | 196 | |
| 14 | 438 | |
| 15 | 228 | |
| 16 | An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Constructbreakdown → | 677 |
| 17 | 42 | |
| 18 | 200 | |
| 19 | TGF-beta: structure, function, and formation. | 50 |
| 20 | 66 |
About John G. Harpel
John G. Harpel is a scholar working on Immunology and Allergy, Hematology and Cancer Research, having authored 21 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), TGF-β signaling in diseases (7 papers) and Protease and Inhibitor Mechanisms (6 papers). The work is most often cited by research in Immunology and Allergy (385 citations), Cancer Research (271 citations) and Hematology (200 citations). John G. Harpel has collaborated with scholars based in United States. Frequent co-authors include Daniel B. Rifkin, Irene Nunes, John S. Munger, Mayumi Abé, Christine N. Metz, David J. Loskutoff, D B Rifkin, Pierre‐Emmanuel Gleizes, Roberta Mazzieri and Filippo G. Giancotti. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.